prod:prod_dcx-login
Xpert® vanA/vanB
Rapid VRE screening for active outbreak prevention and control in around 48 minutes
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
GXVANA/B-CE-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
Collection Device (Pack of 50)
900-0370
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
VRE: A growing concern
The rapid and continuous increase in the percentage of VRE carriage in the EU/EEA is a cause for concern.2
The rapid and continuous increase in the percentage of VRE carriage in the EU/EEA is a cause for concern.2
- Infections and deaths attributable to VRE almost doubled between 2007-20152
- The population-weighted mean percentage for VRE increased from 10.5% in 2015 to 17.3% in 20182
- High resistance levels have been reported from all regions in Europe2
- VRE has a significant impact on patient length of stay, and in turn, hospitalization costs3
(2) ECDC Surveillance Report. Surveillance of antimicrobial resistance in Europe 2018. Accessed Jun 2021. https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2018
(3) Hemapanpairoa J, et al. Does vancomycin resistance increase mortality? Clinical outcomes and predictive factors for mortality in patients with Enterococcus faecium infections. Antibiotics. 2021 Jan;10(2):105.
(4) Saliba R, et al. Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci carriers? J Hosp Infect. 2019 Oct;103(2).
(3) Hemapanpairoa J, et al. Does vancomycin resistance increase mortality? Clinical outcomes and predictive factors for mortality in patients with Enterococcus faecium infections. Antibiotics. 2021 Jan;10(2):105.
(4) Saliba R, et al. Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci carriers? J Hosp Infect. 2019 Oct;103(2).
The Solution
VRE has become a substantive and growing burden in hospitalised patients, prompting the need for earlier and accurate detection.
Xpert vanA/vanB enables:
Xpert vanA/vanB enables:
- Fast identification of VRE in around 45 minutes
- Laboratory efficiencies with on-demand workflows requiring minimal hands-on time, 24/7
- Timely infection control measures to reduce transmission and outbreaks, and enable appropriate use of isolation facilities
(1) Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Rest Infec Control. 2013 Nov;2(30).
The Impact
Fast and accurate PCR testing with Xpert®vanA/vanB greatly improves time to result, allowing healthcare professionals to quickly and appropriately manage patients, reducing transmission and enabling more efficient bed management.4
Optimize Workflow and Patient Management
Optimize Workflow and Patient Management
- Deliver actionable results to clinicians and infection control teams in around 45 minutes
- On-demand STAT testing provides results 24/7
- Ease of use and minimal hands-on-time enables more efficient use of staff time
(4) Saliba R, et al. Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci carriers? J Hosp Infect. 2019 Oct;103(2).
Related Products
Xpert Norovirus
Fast and accurate identification of Norovirus GI & GII in as little as one hour* *With early assay termination for positive results. Reporting negative results in 90 minutes.
Xpert MRSA/SA Blood Culture
Accurate Detection of MRSA and SA in Positive Blood Culture Specimens in About an Hour
Xpert MRSA NxG
Active MRSA surveillance testing in around 70 minutes
Xpert SA Nasal Complete
Pre-surgical S. aureus and MRSA in about 65 minutes
Xpert Carba-R
Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 50 minutes
Xpert C. difficile BT
Detection of Clostridium difficile infection with an independent call-out of binary toxin and differentiation of the 027 strain in around 45 minutes
Xpert MRSA/SA SSTI
Detect MRSA & SA Skin and Soft Tissue Infections In About One Hour